Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

UPDATE: Governor Dewine Signs HB 606 Granting Short Window of Immunity from COVID-19 Personal Injury Lawsuits

Client Alert

On Monday, September 14, as expected, Governor DeWine signed House Bill 606 into law. It will take effect on Sunday, December 13, 2020.

September 9 - The Ohio General Assembly, in Am. Sub. H.B. No. 606, is in the final stages of passing a law that will prohibit lawsuits seeking damages from COVID-19. This includes injury, death, or loss to person or property if the lawsuits are based, in whole or in part, on the exposure to, or the transmission or contraction of the coronavirus, unless the defendant in the lawsuit acted intentionally or recklessly. In circumstances where this immunity does not apply, H.B. 606 prohibits such claims being aggregated and brought as a class action.

Importantly, the law explicitly states that public health or other governmental orders related to COVID-19 do not create any new legal duties of care for the purposes of tort liability and cannot be used as evidence of a breach of any duty of care. 

With this new law, the Ohio General Assembly is recognizing the difficulty businesses face in complying with frequently changing public health orders and CDC recommendations. Additionally, the legislature wants to avoid legal precedents that could subject business and premises owners to liability to members of the public for exposure to airborne viruses, bacteria and germs.   

The lawsuit immunity granted by H.B. 606 is broad. It applies to individuals, corporations, partnerships, associations, health care providers, health care workers, schools, non-profits, governmental entities, religious entities, trusts and estates. It will be short lived, however. The immunity would only be granted to claims arising from March 9, 2020, the date of the Governor’s Executive Order 2020-01D through September 30, 2021. Governor DeWine is expected to sign the bill, which would then take effect in 90 days.

As mentioned in our June 2, 2020 client alert, H.B. 606 previously created a rebuttable presumption that first responders and healthcare workers were eligible for workers’ compensation if they contract COVID-19. Am. Sub. H.B. No. 606 no longer contains this presumption. Therefore, COVID-19 is generally not a compensable workers’ compensation illness in Ohio except in the most exceptional circumstances.

For additional information, please contact Adam D. Fuller, adfuller@bmdllc.com or 330.374.6737, or any member of the L+E or Health Law Team at BMD.


The Ohio Board of Pharmacy’s Latest Batch of Rules: What Providers Should Know

The Ohio Board of Pharmacy released several new rules and proposed amendments to existing rules over the past month that will significantly impact pharmacy operations. Topics range from updates to the Terminal Distributor of Dangerous Drugs license to mobile clinics to mandatory rest breaks for pharmacists of outpatient pharmacies. A summary of the proposed changes is below, along with instructions for commenting on the rules. Your BMD healthcare attorney can help write comment letters and submit the comments on your behalf as well.

Employee or Independent Contractor? New Guidance Issued by the Department of Labor

On January 9, 2024, the U.S. Department of Labor (DOL) issued its long-awaited final rule — effective March 11, 2024 — revising its prior interpretation of worker classifications under the federal Fair Labor Standards Act (FLSA). The new final rule rescinds the standard previously established in 2021, in turn, shifting the analysis of whether a worker is an employee (versus an independent contractor) of a business from a more streamlined “economic reality” test to a more complex “totality of the circumstances” standard.

Increased Medicaid Rates to Take Effect This Month for Ohio Providers

As required by House Bill 33, Ohio’s 2024-2025 operating budget bill, reimbursement rates paid by the Ohio Department of Medicaid will increase for a wide range of providers starting on January 1, 2024.

Corporate Transparency Act Update

The Corporate Transparency Act (“CTA”), with an effective date of January 1, 2024, is set to impose strict reporting guidelines on business owners throughout the country. The following provides a brief update on two aspects of the CTA ahead of its effectiveness next week.

The Second Wave of UnitedHealthcare's Prior Authorization Cuts Started in November

In August 2023, UnitedHealthcare released its plan to eliminate roughly one-fifth of its then-current prior authorization requirements. The first round of prior authorization cuts took effect on September 1, 2023. In that round, UnitedHealthcare eliminated the necessity for some prior authorizations for UnitedHealthcare Medicare Advantage, UnitedHealthcare commercial, UnitedHealthcare Oxford and UnitedHealthcare Individual Exchange plan members. The second and final round of prior authorization cuts began on November 1, 2023. The November 2023 Prior Authorization Cuts apply to the same plans as well as community plans (i.e., Medicaid managed care plans).